Induction of ovulation after GnRH antagonists

Human Reproduction Update

Volumn 6, Issue 4, 2000, Pages 318-321

  Ron El, R ^a   Raziel, A ^a   Schachter, M ^a   Strassburger, D ^a   Kasterstein, E ^a   Friedler, S ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Competitive blockade; GnRH antagonist; Induction of ovulation; LH surge

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN RECEPTOR; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT LUTEINIZING HORMONE; TEVERELIX; TRIPTORELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING COMPETITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS LUTEUM; DOSE RESPONSE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; GONADORELIN RELEASE; HUMAN; HYPOPHYSIS CELL; LUTEAL PHASE; LUTEINIZING HORMONE RELEASE; MONKEY; NONHUMAN; OOCYTE MATURATION; OVARY DISEASE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRIORITY JOURNAL;

EID: 0033846482     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/6.4.318     Document Type: Article

References (18)

1. Perspectives on the use of GnRH antagonists in ovulation induction
2. Effect of administration of gonadotropin-releasing hormone antagonist (Nal-Glu) during the preovulatory period: The luteinizing hormone surge requires secretion of gonadotropin-releasing hormone
3. Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers
4. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility
5. Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle
6. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge
7. The combined use of GnRH antagonists with gonadotrophins or pulsatile GnRH in ovulation induction
8. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist
9. Follicular arrest during the midfollicular phase of the menstrual cycle: A gonadotropin-releasing hormone antagonist imposed follicular-follicular transition
10. Hormonal response to the new potent GnRH antagonist Cetrorelix
11. A single injection of gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: Further evidence for the role of GnRH during the LH surge
12. Pattern of gonadotropin releasing hormone secretion leading up to ovulation in the ewe: Existence of preovulatory gonadotropin-releasing hormone surge
13. Triggering of ovulation by gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist
14. Salvage of low-dose menotrophin cycles in patients with polycystic ovaries by ovulation induction using a gonadotrophin-releasing hormone agonist
15. Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: An overview
16. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): A pilot study with minimal stimulation
17. Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome
18. A surge of gonadotropin-releasing hormone accompanies the estradiol-induced gonadotropin surge in the Rhesus monkey